The facility, set for the Cambridge Biomedical Campus, will be located at Discovery Drive and developed by property company Prologis. Andrew Blevins, senior vice president of life sciences at Prologis, said: "GSK’s decision is a powerful endorsement of Cambridge Biomedical Campus and the unique ecosystem that has been created here. "Prologis invested ahead of demand at Discovery Drive because we believed global life-sciences organisations would continue to choose Cambridge. The announcement marks what leaders have described as a significant milestone for the biomedical campus. Mayor of Cambridgeshire and Peterborough Paul Bristow said: "Cambridge Biomedical Campus has become one of Europe’s leading centres for life sciences because it brings together pioneering research, outstanding healthcare and ambitious businesses in one place.